These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8847198)

  • 1. Issues in drug administration in a psychiatric rehabilitation unit.
    Trauer T; Vaddadi K; Soosai E
    Int J Soc Psychiatry; 1995; 41(3):174-9. PubMed ID: 8847198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
    Rummel-Kluge C; Schuster T; Peters S; Kissling W
    Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study.
    Kurtz MM; Baker E; Pearlson GD; Astur RS
    Schizophr Bull; 2007 Sep; 33(5):1162-70. PubMed ID: 16956984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 5. Virtual reality assessment of medication compliance in patients with schizophrenia.
    Baker EK; Kurtz MM; Astur RS
    Cyberpsychol Behav; 2006 Apr; 9(2):224-9. PubMed ID: 16640484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
    Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
    Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.
    Diaz E; Levine HB; Sullivan MC; Sernyak MJ; Hawkins KA; Cramer JA; Woods SW
    J Psychiatry Neurosci; 2001 Sep; 26(4):325-9. PubMed ID: 11590972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training hospitalized patients with schizophrenia in community reintegration skills.
    Smith TE; Hull JW; MacKain SJ; Wallace CJ; Rattenni LA; Goodman M; Anthony DT; Kentros MK
    Psychiatr Serv; 1996 Oct; 47(10):1099-103. PubMed ID: 8890338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modification.
    Müller P; Bandelow B; Gaebel W; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Schaefer E; Tegeler J
    Br J Psychiatry Suppl; 1992 Oct; (18):140-4. PubMed ID: 1356364
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of an open-door policy combined with a structured activity programme on the residual symptoms of schizophrenic in-patients. A six-month randomised controlled trial in Yanbian, Jilin.
    Jin Z
    Br J Psychiatry Suppl; 1994 Aug; (24):52-7. PubMed ID: 7946232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen.
    Weiden P; Rapkin B; Zygmunt A; Mott T; Goldman D; Frances A
    Psychiatr Serv; 1995 Oct; 46(10):1049-54. PubMed ID: 8829787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
    Hornung WP; Buchkremer G; Redbrake M; Klingberg S
    Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a structural model explaining medication compliance of persons with schizophrenia.
    Seo MA; Min SK
    Yonsei Med J; 2005 Jun; 46(3):331-40. PubMed ID: 15988803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of clozapine and a social learning program for severely disabled psychiatric inpatients.
    Menditto AA; Beck NC; Stuve P; Fisher JA; Stacy M; Logue MB; Baldwin LJ
    Psychiatr Serv; 1996 Jan; 47(1):46-51. PubMed ID: 8925345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depression.
    Calvocoressi L; Libman D; Vegso SJ; McDougle CJ; Price LH
    Psychiatr Serv; 1998 Mar; 49(3):379-81. PubMed ID: 9525801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health beliefs and compliance with antipsychotic medication.
    Budd RJ; Hughes IC; Smith JA
    Br J Clin Psychol; 1996 Sep; 35(3):393-7. PubMed ID: 8889080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
    Kinon BJ; Hill AL; Liu H; Kollack-Walker S
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):97-102. PubMed ID: 12890301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics.
    Kapur S; Ganguli R; Ulrich R; Raghu U
    Schizophr Res; 1991 Dec; 6(1):49-53. PubMed ID: 1686184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.